These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10755675)

  • 1. Commentary: can intensive psychosocial treatments make a difference in a time of atypical antipsychotics and managed care?
    Lauriello J; Bustillo J; Keith SJ
    Schizophr Bull; 2000; 26(1):141-4. PubMed ID: 10755675
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosocial treatments for schizophrenia.
    Liberman RP
    Psychiatry; 1994 May; 57(2):104-14. PubMed ID: 7938330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E
    Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Illness models of schizophrenia and the appropriateness of treatment (author's transl)].
    Alanen YO; Räkköläinen V; Laakso J
    Nervenarzt; 1982 Mar; 53(3):150-3. PubMed ID: 6123088
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychiatric treatment of schizophrenic patients in the clinic].
    Ernst K
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):67-74. PubMed ID: 2579428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication and psychotherapy in the treatment of chronic schizophrenia.
    Sarti P; Cournos F
    Psychiatr Clin North Am; 1990 Jun; 13(2):215-28. PubMed ID: 1972273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive psychosocial therapies for the treatment of schizophrenia.
    Patterson TL; Leeuwenkamp OR
    Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders.
    Larson MK; Walker EF; Compton MT
    Expert Rev Neurother; 2010 Aug; 10(8):1347-59. PubMed ID: 20662758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
    Busch AB; Frank RG; Lehman AF
    Arch Gen Psychiatry; 2004 May; 61(5):442-8. PubMed ID: 15123488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in the prevention and treatment of schizophrenia: a biological perspective.
    Wyatt RJ; Apud JA; Potkin S
    Psychiatry; 1996; 59(4):357-70. PubMed ID: 9029657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse prevention in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2008 Apr; 69(4):e11. PubMed ID: 18507484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Psychology of Schizophrenia: Implications for Biological and Psychotherapeutic Treatments.
    Dewan MJ
    J Nerv Ment Dis; 2016 Aug; 204(8):564-9. PubMed ID: 27479611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outpatient treatment of schizophrenia: an integrated and comprehensive management-oriented approach.
    Roberts R
    Psychiatr Q; 1984; 56(2):91-112. PubMed ID: 6152336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial treatments in schizophrenia: a review of the past 20 years.
    Huxley NA; Rendall M; Sederer L
    J Nerv Ment Dis; 2000 Apr; 188(4):187-201. PubMed ID: 10789995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the psychosocial treatment of schizophrenia: a summary report.
    Mosher LR; Keith SJ
    Am J Psychiatry; 1979 May; 136(5):623-31. PubMed ID: 219718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal therapy: a disorder-relevant psychotherapy for schizophrenia.
    Hogarty GE; Kornblith SJ; Greenwald D; DiBarry AL; Cooley S; Flesher S; Reiss D; Carter M; Ulrich R
    Schizophr Bull; 1995; 21(3):379-93. PubMed ID: 7481569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating pharmacological and psychosocial treatments for schizophrenia.
    Marder SR
    Acta Psychiatr Scand Suppl; 2000; (407):87-90. PubMed ID: 11261649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family management programmes for schizophrenic patients. Prevention of relapse and modification of familial communication patterns.
    Hahlweg K; Feinstein E; Müller U; Dose M
    Br J Psychiatry Suppl; 1989 Jul; (5):112-6. PubMed ID: 2574982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.